Literature DB >> 24850177

Expression of proteins involved in epigenetic regulation in human cutaneous melanoma and peritumoral skin.

Anatoly Uzdensky1, Svetlana Demyanenko, Mikhail Bibov, Svetlana Sharifulina, Oleg Kit, Yury Przhedetski, Viktoria Pozdnyakova.   

Abstract

Epigenetic processes play a critical role in melanoma development. However, little is known about proteins responsible for epigenetic transformations in melanoma cells. The processes in the peritumoral skin within the excision margin are almost unstudied. We studied the changes in expression of 112 proteins involved in epigenetic regulation of gene expression in the human cutaneous melanoma and its peritumoral zone using "The Proteomic Antibody Microarrays" (GRAA2, Sigma-Aldrich). Dimethylated histone H3 at lysines 4 and 9 as well as proteins involved in the regulation of transcription (histone deacetylases HDAC-1 and HDAC-11, DNA methyl-binding protein Kaiso), cell cycle control (protein kinases Aurora-В and PKR, chromosome protein CENP-E , and phosphorylated and acetylated histone H3), DNA repair (phosphorylated histone H2AX), and nuclear protein import (importins α3 and α5/7) were over-expressed in the melanoma tissue as compared with normal skin. At the same time, HDAC-10 and proliferating cell nuclear antigen PCNA were downregulated. In the peritumoral skin, at the excision margin (1-2 cm from the melanoma edge), we observed similar changes in expression of these proteins and, additionally, over-expression of arginine methyltransferases PRMT5 and NAD-dependent histone deacetylase SIR2. Histone methyltransferase G9a and metastasis-associated protein 2 were downregulated. Therefore, epigenetic regulation that requires histone modifications and expression of some regulatory proteins is of importance for melanoma development and propagation. The observed changes in the peritumoral skin may indicate the epigenetic pre-tuning in this zone possibly involved in malignant transformation. These results can be potentially useful for melanoma diagnostics and targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24850177     DOI: 10.1007/s13277-014-2098-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

1.  5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.

Authors:  R J Wozniak; W T Klimecki; S S Lau; Y Feinstein; B W Futscher
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

2.  Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: possible role of NF-kappaB.

Authors:  Nayara Delgado André; Fernando L De Lucca
Journal:  Cancer Lett       Date:  2007-12-08       Impact factor: 8.679

Review 3.  The DNA replication fork in eukaryotic cells.

Authors:  S Waga; B Stillman
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells.

Authors:  Ju-Hee Lee; Eun-Goo Jeong; Moon-Chang Choi; Sung-Hak Kim; Jung-Hyun Park; Sang-Hyun Song; Jinah Park; Yung-Jue Bang; Tae-You Kim
Journal:  Mol Cells       Date:  2010-07-23       Impact factor: 5.034

5.  Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.

Authors:  Jill C Rubinstein; Nam Tran; Shuangge Ma; Ruth Halaban; Michael Krauthammer
Journal:  BMC Med Genomics       Date:  2010-02-09       Impact factor: 3.063

Review 6.  Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.

Authors:  Karin van den Hurk; Hanneke E C Niessen; Jürgen Veeck; Joost J van den Oord; Maurice A M van Steensel; Axel Zur Hausen; Manon van Engeland; Véronique J L Winnepenninckx
Journal:  Biochim Biophys Acta       Date:  2012-03-31

Review 7.  Overexpression of DNA repair genes is associated with metastasis: a new hypothesis.

Authors:  Alain Sarasin; Audrey Kauffmann
Journal:  Mutat Res       Date:  2008-01-16       Impact factor: 2.433

8.  Coilin levels and modifications influence artificial reporter splicing.

Authors:  A A Whittom; H Xu; M D Hebert
Journal:  Cell Mol Life Sci       Date:  2008-04       Impact factor: 9.261

Review 9.  Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer.

Authors:  Owen J Sansom; Kathryn Maddison; Alan R Clarke
Journal:  Nat Clin Pract Oncol       Date:  2007-05

10.  Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi.

Authors:  Debdutta Bandyopadhyay; Jonathan L Curry; Qiushi Lin; Hunter W Richards; Dahu Chen; Peter J Hornsby; Nikolai A Timchenko; Estela E Medrano
Journal:  Aging Cell       Date:  2007-06-18       Impact factor: 9.304

View more
  12 in total

Review 1.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

Review 2.  Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy.

Authors:  Emily Smith; Wei Zhou; Polina Shindiapina; Said Sif; Chenglong Li; Robert A Baiocchi
Journal:  Expert Opin Ther Targets       Date:  2018-05-21       Impact factor: 6.902

Review 3.  Protein arginine methyltransferase 5: a potential cancer therapeutic target.

Authors:  Yuanyang Yuan; Hong Nie
Journal:  Cell Oncol (Dordr)       Date:  2021-01-19       Impact factor: 6.730

4.  Sulforaphane suppresses PRMT5/MEP50 function in epidermal squamous cell carcinoma leading to reduced tumor formation.

Authors:  Kamalika Saha; Matthew L Fisher; Gautam Adhikary; Daniel Grun; Richard L Eckert
Journal:  Carcinogenesis       Date:  2017-08-01       Impact factor: 4.944

Review 5.  Histone deacetylase 10, a potential epigenetic target for therapy.

Authors:  Fajuan Cheng; Bin Zheng; Jianwei Wang; Guiting Zhao; Zhongshun Yao; Zhihong Niu; Wei He
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 6.  Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments.

Authors:  Javier Martinez-Useros; Mario Martin-Galan; Maria Florez-Cespedes; Jesus Garcia-Foncillas
Journal:  Cancers (Basel)       Date:  2021-06-27       Impact factor: 6.639

Review 7.  Tackling malignant melanoma epigenetically: histone lysine methylation.

Authors:  Elias Orouji; Jochen Utikal
Journal:  Clin Epigenetics       Date:  2018-11-22       Impact factor: 6.551

Review 8.  Epigenetics in the Diagnosis and Therapy of Malignant Melanoma.

Authors:  Simeon Santourlidis; Wolfgang A Schulz; Marcos J Araúzo-Bravo; Daniela Gerovska; Pauline Ott; Marcelo L Bendhack; Mohamed Hassan; Lars Erichsen
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

9.  Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis.

Authors:  Hátylas Azevedo; Guilherme Cavalcante Pessoa; Francisca Nathália de Luna Vitorino; Jérémie Nsengimana; Julia Newton-Bishop; Eduardo Moraes Reis; Júlia Pinheiro Chagas da Cunha; Miriam Galvonas Jasiulionis
Journal:  Clin Epigenetics       Date:  2020-08-24       Impact factor: 6.551

10.  Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition.

Authors:  Jie Gao; Ruiqiong Liu; Dandan Feng; Wei Huang; Miaomiao Huo; Jingyao Zhang; Shuai Leng; Yang Yang; Tianshu Yang; Xin Yin; Xu Teng; Hefen Yu; Baowen Yuan; Yan Wang
Journal:  Cell Death Differ       Date:  2021-05-05       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.